0001127602-23-007925.txt : 20230301 0001127602-23-007925.hdr.sgml : 20230301 20230301165147 ACCESSION NUMBER: 0001127602-23-007925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kassler-Taub Kenneth B. CENTRAL INDEX KEY: 0001885219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 23694502 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: 11TH FLOOR CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-02-28 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001885219 Kassler-Taub Kenneth B. 2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR THE WOODLANDS TX 77381 1 SVP, Regulatory & QA Common Stock 2023-02-28 4 M 0 18243 A 104100 D Common Stock 2023-02-28 4 M 0 7086 A 111186 D Common Stock 2023-02-28 4 M 0 27557 A 138743 D Common Stock 2023-02-28 4 F 0 19118 2.17 D 119625 D Restricted Stock Units 2023-02-28 4 M 0 18243 D Common Stock 18243 0 D Restricted Stock Units 2023-02-28 4 M 0 7086 D Common Stock 7086 7087 D Restricted Stock Units 2023-02-28 4 M 0 27557 D Common Stock 27557 55113 D Each restricted stock unit represents a contingent right to receive one share of common stock. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. /s/ Kenneth B. Kassler-Taub, M.D. 2023-03-01